AAT Bioquest

5-FAM Cysteamine

Product Image
Product Image
Gallery Image 1
Ordering information
Catalog Number
Unit Size
Add to cart
Additional ordering information
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
ShippingStandard overnight for United States, inquire for international
Request quotation
Physical properties
Molecular weight435.45
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
StorageFreeze (< -15 °C); Minimize light exposure


Molecular weight
5-Carboxyfluorescein (also known as 5-FAM or 5-Fluorescein) is a fluorescent dye commonly used in molecular biology and biochemistry research. It belongs to the family of fluorescein derivatives and is often used as a fluorescent label or tracer in various applications. 5-FAM cysteamine contains a free thiol group that readily reacts with maleimide and other SH-reactive groups such as iodoacetamide and vinyl sulfone etc. It is an excellent building block for developing fluorescent probes with maleimide-modified biomolecules. The resulting probes exhibit strong fluorescence when excited with light in the blue to green spectral range (absorption maximum at approximately 495 nm and emission maximum at approximately 520 nm). Due to its bright fluorescence, stability, and compatibility with various detection systems, 5-FAM probes are widely used as fluorescent labels for biomolecules. Overall, 5-Carboxyfluorescein is a versatile and widely used fluorescent dye in molecular biology research, offering excellent brightness and compatibility with various labeling and detection methods. Its fluorescent properties make it a valuable tool for visualizing and studying biological molecules and processes. It can be employed to label nucleotides, oligonucleotides, peptides, proteins, antibodies, or other molecules of interest. The labeled molecules can be visualized and detected using fluorescence microscopy, flow cytometry, or other fluorescence-based techniques.


Common stock solution preparation

Table 1. Volume of DMF needed to reconstitute specific mass of 5-FAM Cysteamine to given concentration. Note that volume is only for preparing stock solution. Refer to sample experimental protocol for appropriate experimental/physiological buffers.

0.1 mg0.5 mg1 mg5 mg10 mg
1 mM229.647 µL1.148 mL2.296 mL11.482 mL22.965 mL
5 mM45.929 µL229.647 µL459.295 µL2.296 mL4.593 mL
10 mM22.965 µL114.824 µL229.647 µL1.148 mL2.296 mL

Molarity calculator

Enter any two values (mass, volume, concentration) to calculate the third.

Mass (Calculate)Molecular weightVolume (Calculate)Concentration (Calculate)Moles

Product Family

NameExcitation (nm)Emission (nm)Extinction coefficient (cm -1 M -1)Correction Factor (260 nm)Correction Factor (280 nm)
5(6)-FAM [5-(and-6)-Carboxyfluorescein] *CAS 72088-94-9*493517830000.320.178
5-FAM, SE [5-Carboxyfluorescein, succinimidyl ester] *CAS 92557-80-7*493517830000.320.178
5-FAM ethylenediamine493517830000.320.178
5-FAM cadaverine493517830000.320.178
5-FAM Azide493517830000.320.178
5-FAM Alkyne493517830000.320.178



View all 50 references: Citation Explorer
Development of Thiol-Maleimide hydrogels incorporating graphene-based nanomaterials for cancer chemo-photothermal therapy.
Authors: Costa, Francisco J P and Nave, Micaela and Lima-Sousa, Rita and Alves, Cátia G and Melo, Bruna L and Correia, Ilídio J and de Melo-Diogo, Duarte
Journal: International journal of pharmaceutics (2023): 122713
In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapy.
Authors: Cho, Hanhee and Jeon, Seong Ik and Shim, Man Kyu and Ahn, Cheol-Hee and Kim, Kwangmeyung
Journal: Biomaterials (2023): 122038
Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery.
Authors: Geng, Tianjiao and Leung, Euphemia and Chamley, Lawrence W and Wu, Zimei
Journal: Biomaterials advances (2023): 213388
Enhancing the Activity of Surface Immobilized Antimicrobial Peptides Using Thiol-Mediated Tethering to Poly(ethylene glycol).
Authors: Boden, Andrew and Dart, Alexander and Liao, Tzu-Ying and Zhu, De Ming and Bhave, Mrinal and Cipolla, Laura and Kingshott, Peter
Journal: Macromolecular bioscience (2023): e2200411
Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cells.
Authors: van der Wulp, Willemijn and Gram, Anna M and Bleijlevens, Boris and Hagedoorn, Renate S and Araman, Can and Kim, Robbert Q and Drijfhout, Jan Wouter and Parren, Paul W H I and Hibbert, Richard G and Hoeben, Rob C and van Kasteren, Sander I and Schuurman, Janine and Ressing, Maaike E and Heemskerk, Mirjam H M
Journal: Frontiers in immunology (2023): 1183914
Structure-Activity Relationships of RGD-Containing Peptides in Integrin αvβ5-Mediated Cell Adhesion.
Authors: Yamada, Yuji and Onda, Toru and Wada, Yuri and Hamada, Keisuke and Kikkawa, Yamato and Nomizu, Motoyoshi
Journal: ACS omega (2023): 4687-4693
Total Chemical Synthesis of Palmitoyl-Conjugated Insulin.
Authors: Liu, Mengjie and Li, Qingyang and Delaine, Carlie and Wu, Hongkang and Arsenakis, Yanni and White, Barbara F and Forbes, Briony E and Chandrashekar, Chaitra and Hossain, Mohammed Akhter
Journal: ACS omega (2023): 13715-13720
Generation and structure-activity relationships of novel imidazo-thienopyridine based TLR7 agonists: application as payloads for immunostimulatory antibody drug-conjugates.
Authors: Brant, Michael G and Garnett, Graham A E and Guedia, Joy and Lasalle, Manuel and Lawn, Samuel and Petersen, Mark E and Duan, Renee and Mendez-Campos, José and Hirkala-Schaefer, Truman and Winters, Geoffrey C and Barnscher, Stuart D
Journal: Bioorganic & medicinal chemistry letters (2023): 129348
Improving the stability of thiol-maleimide bioconjugates via the formation of a thiazine structure.
Authors: Gober, Isaiah N and Sharan, Rahul and Villain, Matteo
Journal: Journal of peptide science : an official publication of the European Peptide Society (2023): e3495
Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells.
Authors: Kalinovsky, Daniel V and Kholodenko, Irina V and Kibardin, Alexey V and Doronin, Igor I and Svirshchevskaya, Elena V and Ryazantsev, Dmitriy Y and Konovalova, Maria V and Rozov, Fedor N and Larin, Sergey S and Deyev, Sergey M and Kholodenko, Roman V
Journal: International journal of molecular sciences (2023)